FDA on Tuesday (Aug. 9) authorized a new route of administration that stretches out supply of the two-dose Jynneos monkeypox vaccine, and it expanded the population of people who can receive the shot after HHS declared a public health emergency for monkeypox under section 564 of the Food, Drug and Cosmetic Act. The emergency use authorization allows for a smaller dose of Jynneos -- about one-fifth of the current dosing size -- to be injected intradermally (between the skin) instead...